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Summary
Objective: AvocadoeSoybean Unsaponiﬁables (ASU) represent one of the most commonly used drugs for symptomatic osteoarthritis (OA).
The mechanisms of its activities are still poorly understood. We investigate here the effects of ASU on signaling pathways in mouse or human
chondrocytes.
Methods: Mouse or human chondrocytes stimulated with interleukin-1b (IL1b, 10 ng/ml) and cartilage submitted to a compressive mechanical
stress (MS) were studied in the presence or absence of ASU (10 mg/ml). Nuclear factor kB (NF-kB) activation was assessed by immunoblot,
using an I-kBa antibody, nuclear translocation of NF-kB using p65 antibody, and extra-cellular signal-regulated kinase (ERK)1/2 activation
using phospho and ERK1/2 antibodies. The binding of the p50/p65 complex on DNA was studied by electrophoretic mobility shift assay.
Results: ASU decrease matrix metalloproteinases-3 and -13 expressions and Prostaglandin E2 (PGE2) release in our model. The degradation
of I-kBa is prevented in the presence of ASU as shown by the persistent expression of I-kBa protein in the cytosol when chondrocytes are
stimulated by IL1b or MS. Nuclear translocation of the NF-kB complex is shown by the decrease of the p65 protein from the cytosol, whereas
p65 appears in the nucleus under IL1b stimulation. This translocation is abolished in the presence of ASU. Moreover, bandshift experiments
show an inhibition of the IL1b-induced binding of p50/p65 complexes to NF-kB responsive elements in response to ASU. Finally, among the
different mitogen-activated protein kinases known to be induced by IL1b, ERK1/2 was the sole kinase inhibited by ASU.
Conclusion: These results demonstrate that ASU express a unique range of activities, which could counteract deleterious processes involved
in OA, such as inﬂammation.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is the most common joint disorder char-
acterized by a loss of cartilage more frequently in areas of
increased load, osteophytes, subchondral sclerosis, sub-
chondral cysts and a local inﬂammation. OA is character-
ized by quantitative and qualitative modiﬁcations of
cartilage matrix. An altered imbalance between biosynthe-
sis and degradation of matrix components leads to1This work has been supported by a grant from Expanscience
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373a progressive destruction of the tissue, resulting in exten-
sive articular cartilage damage1,2. The pro-inﬂammatory cy-
tokine interleukin-1b (IL1b), produced by OA chondrocytes
and synovial cells in OA joints, is considered to be one of
the most potent catabolic factors in OA3. IL1b initiates
a number of events leading to cartilage degradation4, like
the transcription of many genes related to catabolic path-
ways such as the inducible nitric oxide synthase (iNOS),
matrix metalloproteinase (MMP) type 1, MMP-3, MMP-13,
and enzymes involved in the synthesis of pro-inﬂammatory
prostaglandins (cyclooxygenase-2, microsomal prostaglan-
din E synthase)5. IL1b also suppresses the biosynthesis
of type II collagen and aggrecan6 and the proliferation of
chondrocytes7. These deleterious effects are mediated by
the activation of different transcription factors. Among
them, nuclear factor kB (NF-kB) plays a major role8. The ac-
tivation of the pathway of mitogen-activated protein kinases
(MAPKs) also plays an important role.
374 O. Gabay et al.: Inhibiting effect of ASU on NF-kB and ERK1/2 in chondrocytesAlong with IL1b, mechanical stimulation (MS) is of critical
importance for the maintenance of normal articular cartilage
integrity. Molecular events regulating responses of chondro-
cytes to compressive mechanical forces have been recently
deﬁned. Mechanoreceptors present at the surface of chon-
drocytes are activated and lead to the activation of intracellu-
lar signaling events. Integrins, the trans-membrane adhesion
and signaling receptors, which physically link extra-cellular
matrix (ECM) to the cytoskeleton, are key players in trans-
ducing mechanical signals via MAPKs and NF-kB9.
MAPKs [i.e., extra-cellular signal-regulated kinase (ERK),
Jun N-terminal kinase (JNK), and the p38 MAPK] regulate
eukaryotic gene expression in response to extra-cellular
stimuli. MAPKs and their downstream kinases phosphory-
late transcription factors, co-regulators and chromatin pro-
teins to initiate transcriptional changes10.
NF-kB is a sequence-speciﬁc transcription factor that regu-
lates expression of numerous genes and can exert protective
or detrimental effects depending upon the cellular con-
text11e13. In resting cells, NF-kB is complexed in the cytosol
with its inhibitory subunit I-kBa. Agonist stimulation promotes
serine phosphorylation of I-kBa which triggers its proteaso-
mal degradation and subsequently activates NF-kB14.
Some symptomatic slow-acting drugs (SYSADOA) have
been shown to be effective in relieving some symptoms of
OA. This class includes glucosamine sulfate, chondroitin sul-
fate, diacerhein and AvocadoeSoybean Unsaponiﬁables
(ASU)15e17. For example, Appelboom et al. have shown, in
a multicenter double blind controlled study using a daily in-
take of ASU during 3 months in patients with femoro-tibial
knee OA, that ASU improve pain and function18. However,
their role as diseasemodifying agents remains controversial.
The mechanisms of action of these SYSADOA com-
pounds are still poorly understood. A few in vitro studies
have been recently published. Glucosamine and chondroitin
sulfate reduce IL1b-induced mRNA expression of MMP-3,
MMP-13, aggrecanase-1, aggrecanase-2, which are key
enzymes of the degradation, and JNK19,20. Rhein partially
reverses the effect of IL1b on tissue inhibitor of metalloprotei-
nase-1 (TIMP-1) and nitric oxide (NO) production21. ASU
increase aggrecan synthesis and reduce catabolic and pro-
inﬂammatory mediator production by human osteoarthritic
chondrocytes22. ASU are potent inhibitors of the production
of IL-8 and prostaglandin E2 (PGE2) by human articular
chondrocytes23. Boumediene et al. have shown that ASU
stimulate transforming growth factor b1 (TGF-b1) and plas-
minogen activator inhibitor (PAI-1) expression in bovine
articular chondrocytes24. Moreover, ASU prevent the osteo-
arthritic osteoblast-induced inhibition of matrix molecule pro-
duction, suggesting that this compound may promote OA
cartilage repair by acting on subchondral bone osteoblasts25.
At doses varying from 0.1 to 2.5 mg/ml, ASU reverse the IL1b
stimulation of MMP-2 and MMP-3. Finally ASU reverse the
IL1b stimulation of TIMP-1 at doses varying from 2.5 to
10 mg/ml in gingival ﬁbroblasts26.
Given that, we examined whether ASU could inhibit NF-
kB and MAPK pathways when chondrocytes are activated
by IL1b or compressive forces.Material and methodsCELL CULTURE AND EXPLANTSAll experiments were performed according to protocols approved by the
French/European ethics committee.
The choice of a model to study articular cartilage is always challenging.
For example, mouse cartilage is chosen here because of the large choiceof biomolecular tools suitable to study it. Furthermore, we decided to work
on costal cartilage rather than articular cartilage because of the extremely
small quantity of the latter available. Costal cartilage is a hyaline cartilage
which has quite the same composition as articular cartilage27. However,
we performed comparative experiments with mouse articular cartilage or
with osteoarthritic human articular cartilage obtained after total knee replace-
ment, in order to validate our model with costal cartilage.
Because this study required a high quantity of intact tissue/cells, we de-
cided to use a recent validated model for compressive MS based on costal
cartilage28. We duplicated in parallel some of our experiments in both mouse
and human articular cartilage.PRIMARY CELL CULTURECostal cartilage was obtained after dissection of newborn Swiss mouse
rib, 5e6 days old29. We obtain chondrocytes after digestion with collagenase
D, 3 mg/ml (Roche Diagnostics, Meylan, France) for 1 h 30 min and over-
night at 0.5 mg/ml. Chondrocytes were grown to conﬂuence in Dulbecco’s
modiﬁed eagle medium (DMEM) (1 g/l glucose) (SigmaeAldrich, St Quen-
tin-Fallavier, France) supplemented with 10% fetal calf serum (Invitrogen,
Eragny, France), 100 U/ml penicillin, 0.1 mg/ml streptomycin and 4 mmol/l
L-glutamine (Sigma) at 37C in the presence of 5% CO2. In each experiment,
cells were made quiescent for 24 h in DMEM without serum and with 2% bo-
vine albumin fatty acid free (Sigma). According to the literature23, cells were
pre-incubated with 10 mg/ml of ASU dissolved in ethanol (Expanscience Lab-
oratories, Epernon, France) during 48 h in DMEM without serum. These
compounds were maintained during the whole period of incubation. ASU
were changed every 24 h. Then, cells were stimulated with or without human
recombinant interleukin-1b (hr-IL-1b) 10 ng/ml (PeproTech, Rocky Hill, NJ)
for 0e10 min. Cells incubated with 0.1% ethanol alone served as control.
Articular cartilage was obtained after dissection of knee joints and femoral
heads of newborn Swiss mouse 5e6 days old as previously described30.
Brieﬂy, chondrocytes were obtained after two digestions of collagenase D,
3 mg/ml for 45 min and a third overnight at 0.5 mg/ml. Chondrocytes were
grown to conﬂuence in DMEM supplemented with 10% fetal calf serum,
100 U/ml penicillin, 0.1 mg/ml streptomycin and 4 mmol/l L-glutamine.
Human osteoarthritic cartilage was obtained after total knee replacement.
Cartilage was cut into small fragments and submitted to sequential enzy-
matic digestions with hyaluronidase, pronase and collagenase (3 g of carti-
lage/10 ml enzymatic solution), adapted from Sanchez et al.21.
Chondrocytes were plated in DMEM (4.5 g/l glucose) (SigmaeAldrich, St
Quentin-Fallavier, France) supplemented with 10% fetal calf serum (Invitro-
gen, Eragny, France), 100 U/ml penicillin, 0.1 mg/ml streptomycin, 2 mmol/l
L-glutamine (Sigma) and N-{2-hydroxyethyl}piperazine-N 0-{2-ethanesulfonic
acid} (HEPES) 10 mM at 37C in the presence of 5% CO2. Cells were
made quiescent for 24 h in DMEM medium without serum and with 2% bo-
vine albumin fatty acid free (Sigma). Cells were pre-incubated with 10 mg/
ml of ASU dissolved in ethanol (Expanscience Laboratories, Epernon,
France) during 48 h in DMEM without serum. These compounds were main-
tained during the whole period of incubation. ASU were changed every 24 h.
Then, cells were stimulated with or without hr-IL-1b 10 ng/ml (PeproTech,
Rocky Hill, NJ) for 0e10 min. Cells incubated with 0.1% ethanol alone served
as control.MECHANICAL STRESSRibs from newborn Swiss mouse 5e6 days old, free of bone and soft tis-
sues, were cut into small pieces (1 mm). Each sample consisted of 50 mg
of costal cartilage, divided into small-pooled segments. They were maintained
in quiescent DMEM without serum, and directly pre-incubated with 10 mg/ml
of ASU dissolved in ethanol (0.1%) for 48 h. These compounds were main-
tained during the whole period of incubation, but ASU were changed every
24 h. Explants incubated with ethanol alone served as controls. After the
incubation period, each sample was placed into individual compression wells
of Biopress culture plate in 1.5 ml of culture medium (DMEM containing
100 U/ml penicillin, 0.1 mg/ml streptomycin, 4 mmol/l L-glutamine, 2%, albu-
min, HEPES 30 mM). All the experiments were performed at 37C in air.
Compression was applied to individual samples by Biopress system (Flexer-
cell International Hillsborough, NC) according to the manufacturer and adap-
ted for cartilage explants28. At each time (30 min, 1 h, 2 h), compressed
(loaded) and uncompressed (unloaded) explants were assessed in parallel
without effectors. Intermittent compression was applied using a sinusoidal
waveform at 0.5 Hz (1 s on, 1 s off) from baseline to 2 h.PREPARATION OF NUCLEAR AND CYTOSOLIC EXTRACTSNuclear and cytosolic extracts were obtained from culture cells. Chondro-
cytes were washed in phosphate buffer saline (PBS) and centrifuged at
1300g for 5 min. The pellet was re-suspended in buffer A [5 mmol/l HEPES,
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0.5% Nonidet P40 (NP40), 0.5 mmol/l dithiothreitol (DTT), 0.1 mmol/l phenyl-
methylsulfonyl ﬂuoride (PMSF), and 5 mg/ml Leupeptine] and homogenized
at þ4C for 10 min. Nuclei and cytosolic fractions were separated by centri-
fugation at þ4C at 3000g for 10 min. The cytosolic fractions (supernatants)
were stored at 80C until analysis. The nuclei (pellets) were re-suspended
and extracted in buffer C [20 mmol/l HEPES, pH 7.9, 0.5 mol/l NaCl, 25%
glycerol, 1.5 mmol/l MgCl2, 50 mmol/l NaF, 0.5 mmol/l PMSF, 0.5 mmol/l ethyl-
enediamine tetraacetic acid (EDTA), 0.5 mmol/l DTT, 5 mg/ml Leupeptine] for
10 min at 4C and centrifuged at 13,000g for 45 min at þ4C. Supernatants
were then stored at 80C.
Only cytosolic extracts were obtained from cartilage explants. Frozen car-
tilage explants were disrupted using a Mixer Mill MM 300 apparatus (Quia-
gen, Hilden, Germany) in 500 ml of cold lysis buffer (20 mM Tris, pH 7.6,
120 mM NaCl, 10 mM EDTA, 10% glycerol, 1% NP40, 100 mM NaF,
10 mM Na4P2O7, 1 mM AEBSF [4-(2-AminoEthyl)BenzeneSulfonyl Fluoride
hydrochloride], 2 mM Na3VO4, 40 mg/ml Leupeptine, 1 mM pepstatin A,
10 mg/ml aprotinin). One steel ball (diameter 5 mm) was added to each sam-
ple and they were mixed for two cycles of 2 min, at 25 pulses/s. Then, the
samples were shaken gently for 1 h at 4C and centrifuged for 1 h
(13,000g, 4C). The supernatants were collected and protein concentrations
were determined.
Protein concentration was determined by the bicinchoninic acid assay kit
(BCA Pierce, Interchim, Montluc¸on, France), or by sodium dodecyl sulfate
(SDS) 0.5% dosage method with UV spectrometer, for the nuclear extracts
(Ultrospec 3100 pro).WESTERN BLOT ANALYSISFor I-kBa and MAPK determination, cytosolic fractions were obtained as
described above. For p65 determination, nuclear extracts were obtained as
described above. Then, similar amounts of proteins (10 mg for cytosolic ex-
tracts and 5 mg for nuclear extracts) were run on SDS-polyacrylamide gel
by electrophoresis and were transferred to polyvinylidene diﬂuoride mem-
branes (PVDF) with kaleidoscope prestained standard (Bio-Rad, Yvry sur
Seine, France). Membranes were blocked in 0.1 mmol/l Tris, pH 7.6, and
0.1 mmol/l NaCl containing 0.1% Tween-20 and 5% dry skimmed milk or bo-
vine serum albumin for 60 min at room temperature. Then, membranes were
incubated overnight with anti-I-kBa, anti-p65 antibodies (Santa Cruz, Tebu-
bio, Le Perray en Yveline, France) anti-phospho-ERK1/2, anti-ERK1/2,
anti-phospho-p38, and anti-p38 (Cell signaling, Tebu-bio, Le Perray en Yve-
line, France) at 4C. After washing, detections were made by incubation with
peroxidase-conjugated secondary antibodies and developed by an en-
hanced chemiluminescence kit (ECL, Amersham, Pharmacia biotec, Orsay,
France), or with super signal West Femto (Pierce, Brebiere, France), and ex-
posed to Kodak Biomax MR-1 ﬁlms. In order to ensure that equal amounts of
total proteins were charged, we also hybridized each membrane with anti-
b-actin (SigmaeAldrich, St Quentin-Fallavier, France).ELECTROPHORETIC MOBILITY SHIFT ASSAY (EMSA)NF-kB consensus oligonucleotides (50-AGTTGAGGGGACTTTCC
CAGGC-30) sense and (50-GCCTGGGAAAGTCCCCTCAACT-30) anti-sense
from Eurogentec (Seraing, Belgium) were [32P] end-labeled with [32P] aden-
osine triphosphate (ATP) and T4 polynucleotide kinase (Promega, Charbon-
nieres, France), respectively. Nuclear extracts (8 mg) were equilibrated for
10 min in a binding buffer [4 mmol/l glycerol, 1 mmol/l MgCl2, 0.5 mmol/l
EDTA, 0.5 mmol/l DTT, 50 mmol/l NaCl, 10 mmol/l TriseHCl, pH 7.5 and
3 mg/ml of poly(dIedC)] (Sigma), and then the labeled probe (0.35 pmol)
was added and incubated for 20 min at room temperature. To establish the
speciﬁcity of the reaction, negative controls without cell extracts and compe-
tition assays with a 100-fold excess of unlabeled oligonucleotide were per-
formed. In competition assays, the corresponding unlabeled probe was
added to the reaction mixture 10 min prior to the addition of the labeled
probe. For supershift assays, 1 mg of antibodies was added and incubated
with nuclear extracts for 1 h, prior to the addition of labeled probe. The spec-
iﬁcity of these antibodies was tested by Western blots. The reaction was
stopped by adding gel-loading buffer (250 mmol/l TriseHCl, 0.2% bromophe-
nol blue, 0.2% xylene cyanol, and 40% glycerol) and run on a non-denaturing
6% acrylamide gel in TriseBorate. The gel was dried and exposed to X-ray
ﬁlm (Kodak Biomax MR-1).Table
Sequences of primers for the qua
mRNA gene Sense (50e30)
HPRT AGG ACC TCT CGA AGT GT
MMP-3 ATG AAA ATG AAG GGT CTT CCG
MMP-13 TGA TGG CAC TGC TGA CAT CATRNA EXTRACTION AND REVERSE TRANSCRIPTASE-
POLYMERASE CHAIN REACTION (RT-PCR)Total RNA was extracted from each sample using the RNeasy Mini Kit
(Qiagen GmbH, Hilden, Germany), according to the manufacturer’s instruc-
tions. A DNAse digestion step (RNAse free DNAse set, Qiagen) was added.
RNA concentration was then measured using a spectrophotometer. The mi-
gration in an agarose gel enabled quality control.
Total RNA (1 mg) was reverse transcribed with Omniscript Kit (Qiagen
GmbH, Hilden, Germany) in a ﬁnal volume of 20 ml containing 50 ng of oligos
dT. The enzyme was then inactivated by heating and the interesting cDNAs
(MMP-3, MMP-13) were quantiﬁed by real-time quantitative PCR using the
LC480 LightCycler* Real-Time PCR (Roche) and Fast Start DNA master
plus SYBR kits (Roche).
Sense and anti-sense PCR primers were designed by the Light Cycler
probe design *software, based on mouse sequence information, for the am-
pliﬁcation of genes of interest (Table I). The PCR reactions were performed
in a 12 ml ﬁnal volume using 0.2 ml of cDNA or, 600 ng of speciﬁc primers and
1 Fast Start DNA master plus SYBR mixture (Roche). PCR ampliﬁcation
conditions were as follows: initial denaturation for 5 min at 95C followed
by 40 cycles consisting of 10 s at 95C, 15 s at 60C and 10 s at 72C.
The generation of speciﬁc PCR products was conﬁrmed by melting-curve
analysis. For each real-time RT-PCR run, cDNAs were run in triplicate in par-
allel with serial dilutions of a puriﬁed DNA standard (from 106 to 103 copies)
for each primer pair to generate a linear standard curve, which was used to
estimate relative quantities of genes of interest normalized for hypoxanthi-
neeguanine phosphoribosyltransferase (HPRT) in the samples.PGE2 ASSAYPGE2 production was measured in the media by a high sensitivity enzyme
immuno-assay kit (EIA, Cayman chemical, Ann Arbor, MI, USA) according to
the manufacturer’s instructions. The limit of detection was 9 pg/ml. PGE2
concentration was analyzed at serial dilutions in duplicate and read against
standard curve.STATISTICAL ANALYSISFor % of inhibition on Western blot ﬁlms, we used Genesnap and Gene-
tools software, in the Syngene system (Cambridge, UK). This device quan-
tiﬁed the bands’ intensity. We previously assigned 100% of intensity to the
controls, and the device calculated the % of intensity of the other bands,
compared to the controls. We report each result on the corresponding
amount of b-actin. Each result is expressed in fold induction with control¼ 1.
Results are expressed as the mean S.E.M. An analysis of variance test
was previously performed to compare mean values between groups, then
StudenteNewmaneKeuls test was used to compare the mean values be-
tween two conditions with the GraphPad Instat version (GraphPad Software,
San Diego, CA).
P values less than 0.05 were considered signiﬁcant.ResultsASU DECREASE THE IL1b-STIMULATED PGE2 RELEASEIL1b stimulation (10 ng/ml) during 24 h leads to an in-
crease of PGE2 release of 385% (P< 0.001). When ASU
is incubated with IL1b for 48 h (10 mg/ml) in starving condi-
tions, IL1b-stimulated PGE2 production is decreased by
55% [Fig. 1(a); P< 0.001].ASU DECREASE THE IL1b-INDUCED MMP-3 AND MMP-13
EXPRESSIONSStimulation with IL1b (10 ng/ml) for 18 h leads to an in-
crease of MMP-3 and MMP-13 expressions by 104.5-fold
and 14.2-fold, respectively (P< 0.001). When ASU isI
ntitative PCR experiments
Anti-sense (50e30)
ATT CAA ATC CCT GAA GTA CT CAT
G GCA GAA GCT CCA TAC CAG CA
TGT AGC CTT TGG AAC TGC TT
Fig. 1. ASU decrease the IL1b-stimulated PGE2 release, MMP-3
and MMP-13 expressions. (a) PGE2 release is decreased by
ASU in costal chondrocytes. Mouse costal chondrocytes were cul-
tured and grown to conﬂuence and serum starved for 24 h followed
by 10 mg/ml ASU incubation during 48 h. Before the end of the
incubation, IL1b was added in the culture media, during 24 h. This
graph represents the mean and the standard deviation (SD) of
data from four different experiments performed in duplicate. Results
are expressed in pg/ml; t test statistical signiﬁcation is represented
by ***P< 0.001. (b) MMP-3 expression is decreased in the pres-
ence of ASU. Mouse costal chondrocytes were cultured and grown
to conﬂuence and serum starved for 24 h followed by 10 mg/ml ASU
incubation during 48 h. Before the end of the incubation, IL1b was
added to the culture media, during 6 or 18 h. This graph represents
the mean and the SD of data from two different experiments per-
formed in duplicate. Results are expressed as ratio between
MMP-3 mRNA and HPRT mRNA; t test statistical signiﬁcation are
represented by **P< 0.01 and ***P< 0.001. (c) MMP-13 expres-
sion is decreased in the presence of ASU. Mouse costal chondro-
cytes were cultured and grown to conﬂuence and serum starved for
24 h followed by 10 mg/ml ASU incubation during 48 h. Before the
end of the incubation, IL1b was added to the culture media, during
6 or 18 h. This graph represents the mean and the SD of data from
two different experiments performed in duplicate. Results are
expressed as ratio between MMP-13 mRNA and HPRT mRNA;
t test statistical signiﬁcation are represented by **P< 0.01 and
***P< 0.001.
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stimulated MMP-3 and MMP-13 expressions are decreased
by 59 and 49%, respectively [Fig. 1(b,c); P< 0.01]. No sig-
niﬁcant effect of ASU is observed at 6 h of IL1b stimulation.IL1b-INDUCED AND MS-INDUCED I-kBa DEGRADATION
IS INHIBITED BY ASUConsistent with NF-kB activation, treatment of costal
chondrocytes [Fig. 2(a)] with IL1b (10 ng/ml) causes a rapid
inhibition of cytosolic I-kBa expression, from 2 min (82%,
P< 0.001) to 5 min (85%, P< 0.001). The inhibition of
I-kBa expression is reversed in the presence of ASU
(10 mg/ml) at 2 and 5 min (P< 0.001) [Fig. 2(a)]. We found
the same results in articular chondrocytes [Fig. 2(c)] and in
human osteoarthritic chondrocytes [Fig. 2(d)]. Interestingly,
when MS is applied on cartilage explants, cytosolic I-kBa
expression is also inhibited at 60 min (90%, P< 0.001) com-
pared to non-compressed cartilage, suggesting that MS
activates NF-kB pathway. ASU almost completely reverse
MS-induced I-kBa degradation at 1 h (P< 0.001) [Fig. 3(a)].
A faster migrating band is visible on Fig. 3(a). Although no
deﬁnitive explanation can be postulated, we hypothesize
that the protein extraction method leads to release of I-kBa
degradation products. This hypothesis is strengthened by
the fact that this band is not present in IL1b experiments.IL1b-INDUCED NUCLEAR TRANSLOCATION OF THE p50/p65
HETERODIMER IS INHIBITED BY ASUWhen I-kBa is degraded, the heterodimer p50/p65 is trans-
located from the cytosol to the nucleus where it binds to
speciﬁc responsive elements on promoters of genes. We
see here that treatment of chondrocytes with IL1b causes
the translocation of the p65 subunit at 10 and 15 min, from
cytosol to nucleus, by a decrease of p65 subunit expression
in the cytosol (55%, P< 0.001 and 45% P< 0.05, respec-
tively, compared to the control) and an increase of the p65
subunit expression in the nucleus (105%, P< 0.001 and
95%, P< 0.001, respectively, compared to the control).
This translocation is inhibited when ASU were co-incubated
with IL1b at 10 and 15 min (P< 0.001) [Fig. 4(a)].ASU INHIBIT THE IL1b-INDUCED BINDING OF p50/p65
HETERODIMER TO NF-kB RESPONSIVE ELEMENTNuclear extracts from IL1b-stimulated chondrocytes
yielded one speciﬁc electrophoretic band in an EMSA
(Fig. 5). Compared to controls non-stimulated with IL-1b,
we see signiﬁcant bands at 10 and 15 min when cells are
IL1b-stimulated, meaning the binding of NF-kB on the re-
sponsive element (columns 5, 6, 7) compared to the controls
(columns 1, 3, 4) whereas we do not see these bands when
cells are incubated with ASU at 10 and 15 min (columns 8,
9). In order to conﬁrm the speciﬁcity of the binding, speciﬁc
antibodies raised against p50 and p65 proteins were incu-
bated with the nuclear extracts stimulated with IL1b for
15 min. Supershift complexes were seen in the presence
of these two antibodies, suggesting that these bands corre-
sponded to p50/p65 heterodimers. p50/p65 heterodimer
binding is inhibited in the presence of ASU.ASU INHIBIT THE IL1b-INDUCED AND MS-INDUCED
PHOSPHORYLATION OF ERK1/2 PATHWAYIn costal chondrocytes [Fig. 6(a)], stimulation with IL1b
for 2e7 min triggers the increased expression of the
Fig. 2. I-kB expression in chondrocytes. (a) The IL1b-induced inhibition of cytosolic I-kBa expression is counteracted by ASU in costal chon-
drocytes. Mouse costal chondrocytes were cultured and grown to conﬂuence and serum starved for 24 h followed by 10 mg/ml ASU incubation
during 48 h. Then, cells were incubated in the presence or absence of IL1b 10 ng/ml for 0e10 min. Cytosolic extracts were electrophoresed
under reducing, denaturing conditions, stained with afﬁnity-puriﬁed anti-I-kBa antibody and b-actin, and visualized by ECL. The ﬁgure presents
data from one of three independent experiments that produced similar results. (b) This graph represents the mean S.E.M. of the values of
three different experiments and expressed in fold induction. (c) The IL1b-induced inhibition of cytosolic I-kBa expression is counteracted
by ASU in mouse articular chondrocytes. Mouse articular chondrocytes from knee and hip joints, were cultured and grown to conﬂuence
and serum starved for 24 h followed by 10 mg/ml ASU incubation during 48 h. Then, cells were incubated in the presence or absence of
IL1b 10 ng/ml for 0e10 min. Cytosolic extracts were electrophoresed under reducing, denaturing conditions, stained with afﬁnity-puriﬁed
anti-I-kBa antibody and b-actin, and visualized by ECL. (d) The IL1b-induced inhibition of cytosolic I-kBa expression is counteracted by
ASU in human osteoarthritic articular chondrocytes. Human articular osteoarthritic chondrocytes from knee joint were cultured and grown
to conﬂuence and serum starved for 24 h followed by 10 mg/ml ASU incubation during 48 h. Then, cells were incubated in the presence
or absence of IL1b 10 ng/ml for 0e10 min. Cytosolic extracts were electrophoresed under reducing, denaturing conditions, stained with
afﬁnity-puriﬁed anti-I-kBa antibody and b-actin, and visualized by ECL. This ﬁgure presents data from one experiment.
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Fig. 3. The MS-induced inhibition of cytosolic I-kBa expression is counteracted by ASU in costal cartilage explants. (a) Mouse costal cartilage
explants were cultured and serum starved for 48 h in the presence or absence of 10 mg/ml ASU. Explants were submitted to MS of compres-
sion from baseline to 1 h. Cytosolic extracts were examined by Western blot analysis using antibodies raised against I-kBa and b-actin. The
ﬁgure presents data from one of three independent experiments that produced similar results. (b) This graph represents the mean S.E.M. of
the values of three different experiments and expressed in fold induction.
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spectively, P< 0.01). Similar results are observed with
articular cartilage, but started at 5 min [Fig. 6(c)] and
with human articular osteoarthritic chondrocytes
[Fig. 6(d)]. MS also induced the activation of the ERK1/
2 pathway in cartilage explants after 2 h of compression
compared to controls (76%, P< 0.001). We do not see
ERK pathway activation before 2 h in this model
[Fig. 7(a)]. Moreover, we see that incubation with ASU
signiﬁcantly decreases this phosphorylation of ERK1/2
from more 50% at 5 min in costal cartilage stimulated
with IL1b (P< 0.01) and from 38% (P< 0.001) in ex-
plants after 2 h of compression [Figs. 6(a) and 7(a)],
while amounts of non-phosphorylated ERK pathways
stay unchanged.ASU HAVE NO EFFECT ON IL1b-INDUCED AND MS-INDUCED
PHOSPHORYLATION OF p38Whereas we see a very signiﬁcant phosphorylation of
p38 pathway after stimulation with IL1b at 2, 5 and 10 min
compared to controls (100%, 200%, 170%, P< 0.001, re-
spectively) [Fig. 8(a)], we only see discrete changes after in-
cubation with ASU for 2e10 min compared to controls
(P< 0.05 at 2 min), suggesting that ASU have a very small
effect on this activation, while amounts of non-phosphory-
lated p38 remain unchanged. In the same way, MS applied
up to 2 h shows a phosphorylation of p38, strongly signiﬁ-
cant at 1 h (120%, P< 0.001), compared to controls
[Fig. 9(a)] but incubation with ASU does not show any
change after 1 or 2 h of compression meaning that ASU
have no effect on this activation, while amounts of non-
phosphorylated p38 are unchanged (P> 0.05) (Fig. 9).
Similar results were found with a speciﬁc antibody
raised against the phosphorylated form of JNK (data not
shown).Discussion
Despite the fact that ASU represent one of the most com-
monly used drugs to treat symptoms of OA in Europe, the
molecular mechanisms of its activity are still poorly under-
stood. The present study is the ﬁrst to examine the effect
of ASU on chondrocyte intracellular responses toward the
stimulation with IL1b and mechanical stress. It describes
a novel mechanism of ASU-mediated activity.
In the present study, ASU were found to prevent IL1b and
mechanical stress-induced NF-kB activations in chondro-
cytes. NF-kB activation is mandatory for the expression of
many genes involved in chondrocyte activation such as
interleukin-6 (IL-6), interleukin-8 (IL-8), macrophage inﬂam-
matory protein-1b (MIP1b), NO and PGE2 which are pro-
inﬂammatory mediators31. Recent studies have shown
inhibitory effects of ASU on some of these pro-inﬂammatory
and pro-degradative mediators. Henrotin et al. have shown
a decrease of stromelysin-1 (MMP-3), a key enzyme of the
degradation, IL-6, IL-8, MIP1b, NO and PGE2 production in
chondrocytes cultured 12 days in alginate beads, in a dose-
dependent manner22.
ASU were able to counteract NF-kB and ERK1/2 path-
ways but not p38 and JNK. p38 and JNK are known to trig-
ger the expression of the above inﬂammatory mediators
and matrix degrading enzymes. Since NF-kB is a common
pathway leading to the induction of these mediators, we
consider that the inhibitory effect of ASU is mainly due to
the inhibition of the NF-kB pathway.
This study shows an activation of the NF-kB and the
ERK1/2 pathways under mechanical stress of compres-
sion in mouse chondrocytes. Recent studies have shown
activation of these pathways in IL1b-stimulated chondro-
cytes, but studies with a compressive mechanical stress
have been poorly investigated. Fanning et al. have shown
phosphorylation of ERK1/2, p38 MAPK and stress-activated
Fig. 4. Nuclear translocation of NF-kBdimer complex: inhibitionwith ASU. (a)Mouse costal chondrocyteswere cultured and grown to conﬂuence
and serum starved for 24 h followed by 10 mg/ml ASU incubation during 48 h. Then, cells were incubated in the presence or absence of IL1b
10 ng/ml for 0e15 min. Cytosolic and nuclear extracts were electrophoresed under reducing, denaturing conditions, stained with afﬁnity-puriﬁed
anti-p65 antibody and b-actin, and visualized by ECL. The ﬁgure presents data from one of three independent experiments that produced similar
results. (b,c) These graphs represent the mean S.E.M. of the values of three different experiments and expressed in fold induction.
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sion in bovine cartilage32. Agarwal et al. have shown
that a strain mimicked the action of IL1b and induced rapid
translocation of NF-kB in rabbit articular cartilage
chondrocytes14.
Which one of the several components present in the ASU
preparation is responsible for the effect shown in this paper
is debatable. Although we do not know yet which compo-
nent is (are) involved in the effects, phytosterols could be
at least one of the active effectors, since it has been re-
ported in the literature that phytosterols have an anti-inﬂam-
matory effect33.
We hypothesize that ASU could counteract NF-kB activity
because of the presence of the sterols. Sterols inhibitreactive oxygen species (ROS) production in different cell
types34. This effect is due to its action on endogenous intra-
cellular anti-oxidant defences.
The signaling pathways activated by oxidative stress
have been the subject of intense research in the ﬁeld of
OA pathophysiology. The redox state of the cell may act
as a molecular switch that regulates the activity of many
genes in concert. Several lines of evidence demonstrate
a coincidence of macromolecular oxidative damage and
the development of OA35. It is also accepted that ROS
generation by IL1b is associated with cartilage
degradation36.
NF-kB is one of the main redox-regulated transcription
factors. Therefore, it is conceivable that ASU inhibit the
Fig. 5. NF-kB heterodimer p50/p65 complex binding on DNA: inhibition with ASU. Bandshift assays were performed as described in Materials
and methods. Mouse costal chondrocytes were cultured and grown to conﬂuence and serum starved for 24 h followed by 10 mg/ml ASU
incubation during 48 h. Then, cells were incubated in the presence or absence of IL1b 10 ng/ml for 0e15 min. A 100-fold excess of unlabeled
oligonucleotide consensus sequence wt over the NF-kB probe concentration was added to the nuclear proteins for 15 min before adding the
NF-kB probe. Antibodies (1 ml of pure stock solution) raised against p50 or p65 were incubated with chondrocytes nuclear extracts for 15 min
at 4C prior to adding poly (dIedC). Nuclear extracts were then submitted to electrophoresis run on a non-denaturing 6% acrylamide gel in
TriseBorate. The ﬁgure presents data from one of two independent experiments that produced similar results.
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generation.
ASU may also block I-kBa release by modulating the ac-
tivation and/or expression of upstream signaling compo-
nents that are also activated by ROS such as MAPKs37.
We show here that ASU inhibit the MAPK pathway activa-
tion induced by biochemical and physical stresses that up-
regulate ROS in chondrocytes. These results suggest that
the attenuation of ERK phosphorylation due to the ROS
scavenging ability of ASU may be associated with NF-kB
suppression.
Interestingly, vitamin E protects cellular components
from free radical-mediated damage and reactive lipid per-
oxidation38. Recent studies have suggested that vitamin E
could interfere with NF-kB activation by preventing itsbinding to its responsive element39. Therefore, we cannot
exclude that the inhibitory effect of ASU on NF-kB could
also be mediated from its vitamin E component.
A critical question concerns the extrapolation of our
in vitro data to the clinical effects of ASU. Since the concen-
tration of ASU in blood and synovial ﬂuid is not known, the
question remains debatable.
Moreover, ASU are composed of different components
and the active ones need to be determined before deﬁning
the optimal ASU concentration for in vitro experiments.
Taken together, our data provide for the ﬁrst time intracel-
lular mechanisms of action for ASU, a product largely used
by patients for treating symptoms of OA. Further studies are
needed to explore the role of the different compounds pres-
ent in ASU, such as phytosterols.
Fig. 6. IL1b-induced phospho-ERK1/2 activation in chondrocytes: inhibition with ASU. (a) IL1b-induced phospho-ERK1/2 activation in costal
chondrocytes: inhibition with ASU. Mouse costal chondrocytes were cultured and grown to conﬂuence and serum starved for 24 h followed by
10 mg/ml ASU incubation during 48 h. Then, cells were incubated in the presence or absence of IL1b 10 ng/ml for 0e10 min. Cytosolic extracts
were electrophoresed under reducing, denaturing conditions, stained with afﬁnity-puriﬁed anti-phospho-p44/p42 and p44/p42 antibodies, and
visualized by ECL. The ﬁgure presents data from one of three independent experiments that produced similar results. (b) This graph repre-
sents the mean S.E.M. of the values of three different experiments and expressed in fold induction. (c) IL1b-induced phospho-ERK1/2 acti-
vation in mouse articular chondrocytes: inhibition with ASU. Mouse articular chondrocytes were cultured and grown to conﬂuence and serum
starved for 24 h followed by 10 mg/ml ASU incubation during 48 h. Then, cells were incubated in the presence or absence of IL1b 10 ng/ml for
0e10 min. Cytosolic extracts were electrophoresed under reducing, denaturing conditions, stained with afﬁnity-puriﬁed anti-phospho-p44/p42
and b-actin antibodies, and visualized by ECL. (d) IL1b-induced phospho-ERK1/2 activation in human articular chondrocytes: inhibition with
ASU. Human osteoarthritic articular chondrocytes were cultured and grown to conﬂuence and serum starved for 24 h followed by 10 mg/ml
ASU incubation during 48 h. Then, cells were incubated in the presence or absence of IL1b 10 ng/ml for 0e10 min. Cytosolic extracts
were electrophoresed under reducing, denaturing conditions, stained with afﬁnity-puriﬁed anti-phospho-p44/p42 and b-actin antibodies,
and visualized by ECL.
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Fig. 7. MS-induced phospho-ERK1/2 activation in mouse costal cartilage explants: inhibition with ASU. (a) Mouse costal cartilage explants
were cultured and serum starved for 48 h in the presence or absence of 10 mg/ml of ASU. Explants were submitted to MS of compression
from baseline to 2 h. Cytosolic extracts were examined by Western blot analysis using antibodies that recognize phospho-p44/p42 and
p44/p42. The ﬁgure presents data from one of three independent experiments that produced similar results. (b) This graph represents the
mean S.E.M. of the values of three different experiments and expressed in fold induction.
Fig. 8. IL1b-induced p38 activation in mouse costal chondrocytes: absence of inhibition with ASU. (a) Mouse costal chondrocytes were cul-
tured and grown to conﬂuence and serum starved for 24 h followed by 10 mg/ml ASU incubation during 48 h. Then, cells were incubated in the
presence or absence of IL1b 10 ng/ml for 0e10 min. Cytosolic extracts were electrophoresed under reducing, denaturing conditions, stained
with afﬁnity-puriﬁed anti-phospho-p38, p38 antibodies, and visualized by ECL. The ﬁgure presents data from one of three independent exper-
iments that produced similar results. (b) This graph represents the mean S.E.M. of the values of three different experiments and expressed in
fold induction.
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Fig. 9. MS-induced p38 activation in mouse costal cartilage explants: absence of inhibition with ASU. (a) Mouse costal cartilage explants were
cultured and serum starved for 48 h in the presence or absence of 10 mg/ml ASU. Explants were submitted to MS of compression from base-
line to 2 h. Cytosolic extracts were examined by Western blot analysis using antibodies raised against phospho-p38 and p38. The ﬁgure pres-
ents data from one of three independent experiments that produced similar results. (b) This graph represents the mean S.E.M. of the values of
three different experiments and expressed in fold induction.
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